EUVIMEDEUVIMED entdecken
Crossref

A novel mechanism of cannabidiol in suppressing ovarian cancer through LAIR ‐1 mediated mitochondrial dysfunction and apoptosis

Li Ma, Huachang Zhang, Chuntong Liu, Mengke Liu, Fugen Shangguan, Yan Liu, Shude Yang, Hua Li, Jing An, Shuling Song, Qizhi Cao iD, Guiwu Qu

Environmental Toxicology · 2023-05 · 38 (5) · 1118-1132

DOI: 10.1002/tox.23752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 22.02.2023. Verfasst von Li Ma und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Binzhou Medical University, Shandong Province, China. Hauptthemen laut MEDLINE: Cannabidiol, Ovarian Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation Joint Fund, Yantai Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD) is a nonpsychoactive cannabinoid compound. It has been shown that CBD can inhibit the proliferation of ovarian cancer cells, but the underlying specific mechanism is unclear. We previously presented the first evidence for the expression of leukocyte‐associated immunoglobulin‐like receptor 1 (LAIR‐1), a member of the immunosuppressive receptor family, in ovarian cancer cells. In the present study, we investigated the mechanism by which CBD inhibits the growth of SKOV3 and CAOV3 ovarian cancer cells, and we sought to understand the concurrent role of LAIR‐1. In addition to inducing ovarian cancer cell cycle arrest and promoting cell apoptosis, CBD treatment significantly affected the expression of LAIR‐1 and inhibited the PI3K/AKT/mTOR signaling axis and mitochondrial respiration in ovarian cancer cells. These changes were accompanied by an increase in ROS, loss of mitochondrial membrane potential, and suppression of mitochondrial respiration and aerobic glycolysis, thereby inducing abnormal or disturbed metabolism and reducing ATP production. A combined treatment with N ‐acetyl‐ l ‐cysteine and CBD indicated that a reduction in ROS production would restore PI3K/AKT/mTOR pathway signaling and ovarian cancer cell proliferation. We subsequently confirmed that the inhibitory effect of CBD on the PI3K/AKT/mTOR signal axis and mitochondrial bioenergy metabolism was attenuated by knockdown of LAIR‐1. Our animal studies further support the in vivo anti‐tumor activity of CBD and suggest its mechanism of action. In summary, the present findings confirm that CBD inhibits ovarian cancer cell growth by disrupting the LAIR‐1‐mediated interference with mitochondrial bioenergy metabolism and the PI3K/AKT/mTOR pathway. These results provide a new experimental basis for research into ovarian cancer treatment based on targeting LAIR‐1 with CBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolOvarian NeoplasmsAnimalsFemaleHumansApoptosisCell Line, TumorCell ProliferationMitochondriaPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesTOR Serine-Threonine KinasesReceptors, Immunologic

Stichwörter der Autor:innen

CannabidiolLAIR-1PI3K/AKT/mTORROScell bioenergeticsovarian cancer

Substanzen

CannabidiolPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesTOR Serine-Threonine Kinasesleukocyte-associated immunoglobulin-like receptor 1Receptors, Immunologic

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Binzhou Medical University, Shandong Province, China.
  • Fungal Laboratory, Jining First People's Hospital, Jining, Shandong Province, China.
  • Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Yantai Key Laboratory of Sports Injury and Rehabilitation, Health Commission of Shandong Province of Medicine and Health Key Laboratory of Sports Injury and Rehabilitation, Yantai Affiliated Hospital of Binzhou Medical…
  • Department of Edible Mushrooms, School of Agriculture, Ludong University, Yantai, Shandong Province, China.
  • Department of Gynecology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, Shandong Province, China.

ORCID-Profile: Qizhi Cao

Förderung

  • National Natural Science Foundation of China
  • Shandong Provincial Natural Science Foundation Joint Fund
  • Yantai Science and Technology Plan Project
  • Youth Innovation and Technology Support Program in Colleges and Universities of Shandong Province

Zitieren

APA

Ma, L., Zhang, H., Liu, C., Liu, M., Shangguan, F., Liu, Y., Yang, S., Li, H., An, J., Song, S., Cao, Q., & Qu, G. (2023). A novel mechanism of cannabidiol in suppressing ovarian cancer through LAIR ‐1 mediated mitochondrial dysfunction and apoptosis. Environmental Toxicology, 38(5), 1118-1132. https://doi.org/10.1002/tox.23752

Vancouver

Ma L, Zhang H, Liu C, Liu M, Shangguan F, Liu Y, et al. A novel mechanism of cannabidiol in suppressing ovarian cancer through LAIR ‐1 mediated mitochondrial dysfunction and apoptosis. Environmental Toxicology. 2023;38(5):1118-1132. doi:10.1002/tox.23752

BibTeX
@article{Ma2023,
  author = {Ma, Li and Zhang, Huachang and Liu, Chuntong and Liu, Mengke and Shangguan, Fugen and Liu, Yan and Yang, Shude and Li, Hua and An, Jing and Song, Shuling and Cao, Qizhi and Qu, Guiwu},
  title = {A novel mechanism of cannabidiol in suppressing ovarian cancer through LAIR ‐1 mediated mitochondrial dysfunction and apoptosis},
  journal = {Environmental Toxicology},
  year = {2023},
  volume = {38},
  number = {5},
  pages = {1118--1132},
  doi = {10.1002/tox.23752}
}
Kostenlos starten →